Verano Holdings (VRNO) Change in Receivables (2021 - 2026)
Verano Holdings (VRNO) reported Change in Receivables of $1.7 million for Q1 2026, little changed year-over-year from $1.7 million in Q1 2025, and up 226.99% quarter-over-quarter from -$1.3 million in Q4 2025.
Verano Holdings (VRNO) Change in Receivables (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Change in Receivables data on file, last reported at $1.7 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $1.7 million, changed 0.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.3 million (down 541.98% YoY), and the FY2025 annual result was -$5.4 million, down 295.01% from the prior year.
- Change in Receivables climbed to $1.7 million in Q1 2026 per VRNO's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Change in Receivables peaked at $9.6 million in Q2 2023 and troughed at -$7.7 million in Q2 2025.
- A 5-year average of $1.2 million and a median of $1.7 million in 2026 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables jumped 520.82% in 2023, then tumbled 522.33% in 2025.
- A 5-year view of Change in Receivables shows it stood at $1.2 million in 2022, then surged by 351.58% to $5.6 million in 2023, then plunged by 199.18% to -$5.5 million in 2024, then soared by 75.75% to -$1.3 million in 2025, then surged by 226.99% to $1.7 million in 2026.
- Business Quant data shows VRNO's Change in Receivables at $1.7 million in Q1 2026, -$1.3 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | -1.34 Mn |
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | -7.72 Mn |
| Jun 30, 2025 | -7.72 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Dec 31, 2023 | 5.58 Mn |